$0.610
+0 (+0%)
At Close: Jun 03, 2026
Oragenics, Inc. to Present Interim Data on AG013 at the European Society of Medical Oncology Congress
12:00pm, Monday, 23'rd Sep 2019
Oragenics, Inc. (NYSE American:OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (“OM”), today announces that an abstrac
Who Has Been Buying Oragenics, Inc. (NYSEMKT:OGEN) Shares?
02:41pm, Tuesday, 10'th Sep 2019
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...
Sabby Management, Llc Buys Actinium Pharmaceuticals Inc, Ampio Pharmaceuticals Inc, China Jo-Jo ...
12:00am, Tuesday, 20'th Aug 2019The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings
12:00am, Thursday, 15'th Aug 2019Oragenics, Inc. (NYSEMKT:OGEN): What Does Its Beta Value Mean For Your Portfolio?
01:46pm, Wednesday, 10'th Jul 2019
Anyone researching Oragenics, Inc. (NYSEMKT:OGEN) might want to consider the historical volatility of the share price...
Sign In
Buy OGEN